Aspen Neuroscience has released 6-month data from the first three patients dosed in the ASPIRO Phase 1/2a trial of ANPD001, an investigational autologous dopaminergic neuronal precursor cell (DANPC) ...

Aspen Neuroscience scientists, led by Chief Scientific Officer Xiaokui Zhang, Ph.D., will present at the International Society for Gene & Cell Therapy (ISCT) Annual Meeting, held this week May 7-10 at ...

Aspen Neuroscience, Inc., a private biotechnology company developing personalized, autologous cell therapies, has appointed ...

However, despite the high production, banana growers are experiencing challenges due to certain plant diseases or wilt, which cause significant losses. According to the Department of Science and ...

But as you glance down at your feet, you hesitate. Thick, discolored, brittle nails stare back at you-a reminder of the toenail fungus that just won't go away. Sound familiar? You're not alone.

Health and Human Services Secretary Robert F. Kennedy Jr. has made some claims about Americans with chronic diseases that should be challenged with critical thinking. (Alex Wong/Getty Images ...

South African global pharmaceutical giant Aspen Pharmacare has found itself caught in Trump tariff-related market volatility, as it witnessed R22 billion being wiped off its JSE market ...

The host of life on ice includes bacteria, viruses, fungi, protozoa, even microscopic animals like nematodes, some dead and some alive in suspended animation. Yarzábal actually started studying ...

inhibitor—a new mechanism of action with the potential to address a range of neutrophil-mediated inflammatory diseases. The ASPEN trial represents a transformative step forward for the millions of ...

Now, researchers have developed a building material made of mycelium—the tubular, branching filaments found in most fungi—and bacteria cells. As detailed in a study published last week in the ...